Search results
Azithromycin shows promise for putting asthma into remission
Medical Xpress· 10 hours agoProfessor Peter Gibson from the HMRI Asthma and Breathing program says the findings were very promising. Biologics are injection medicines, cost-prohibitive in low- and middle-income ...
Mapping a way to identify neighborhoods with a high risk of severe child asthma
Medical Xpress· 5 days agoSkeen, a pediatric pulmonologist with Children's Hospital Colorado, will become an assistant...
Could better asthma inhalers help patients, and the planet too?
NPR· 19 hours agoIn Sweden, where the vast majority of patients use dry powder inhalers, rates of severe asthma are...
AMGEN HIGHLIGHTS NEW COPD, ASTHMA AND VASCULITIS RESEARCH AT ATS 2024
WFRV 5 Green Bay· 6 days agoConference taking place May 12-22 in San Diego. "We look forward to presenting encouraging data from our Phase 2a COURSE trial in COPD with Tezspire and our Phase 1 investigational study of ...
Foresee Pharmaceuticals Announces First Subject Dosed in its First-in-Human Clinical Trial of FP-020
WTNH-TV New Haven· 7 days agoForesee Pharmaceuticals (TPEx: 6576), ("Foresee") today announced that the first subject has been...
New research reveals troubling health implications of concurrent exposure to extreme heat and...
The Cool Down via Yahoo News· 3 days agoIt can also worsen chronic conditions like cardiovascular...Meanwhile, the effects of wildfire smoke...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 5 days agoPDUFA Target Action Date of June 26, 2024 Eight posters including two oral presentations support potential of ensifentrine,an investigational, first-in-class, selective, dual inhibitor of PDE3 and PDE4 LONDON and RALEIGH, N.C., May 02, 2024
Progressing Interstitial Lung Abnormalities Linked to Respiratory Distress
MedPage Today· 7 days agoIn smokers without known interstitial lung disease (ILD), worsening pulmonary parenchymal...